Stage III Ovarian Cancer: Pam's Survivor Story

Patient Info: Pam Scarpino, female | Stage III

Pam had no evidence of disease in March 2010 after treatment for recurrence and remained in remission at the time of the story.

MD AndersonRead more →

Ovarian Cancer With Severe Dermatomyositis During Treatment

Patient Info: Anonymized, female, 60s | Stage III

Biomarkers: BRCA1 mutation

She continued paclitaxel and carboplatin while being treated for severe dermatomyositis and later described herself as finally on the mend.

PubMed CentralRead more →

High-Grade Serous Ovarian Cancer With Markedly Elevated Amylase

Patient Info: Anonymized, female | Stage III

At 6 months, she was receiving 3 additional chemotherapy cycles after an excellent initial clinical and imaging response, with later marker changes reflecting periods of progression and response.

PubMed CentralRead more →

Stage III Ovarian Cancer Treated Over Years Before a Separate Oral Cancer

Patient Info: Anonymized, female, 40s | Stage III

Biomarkers: BRCA1 mutation

After prolonged treatment for recurrent ovarian cancer, follow-up visits documented her as free from ovarian disease.

PubMed CentralRead more →

Ovarian Cancer Recurrence Complicated by a Benign Surgical Stitch Reaction

Patient Info: Anonymized, female, 40s | Stage III

Diffuse peritoneal relapse was confirmed, and she remained on third-line chemotherapy with persistent evidence of ovarian cancer.

PubMed CentralRead more →

Stage III BRCA1 Ovarian Cancer: Meredith's Survivor Story

Patient Info: Meredith Ippolito, female | Stage III

Biomarkers: BRCA1 mutation

Meredith was told she was cancer-free in April 2009 and continued follow-up visits every 6 months.

MD AndersonRead more →

Stage III Ovarian Cancer Diagnosed With a Separate Vaginal Cancer

Patient Info: Anonymized, 50s | Stage III

A whole-body PET scan 4 weeks after treatment found no active malignant disease, and she continued regular follow-up.

PubMed CentralRead more →

Stage III Ovarian Cancer in a BRCA1 Carrier With Long-Term Disease Control

Patient Info: Anonymized, 60s | Stage III

Biomarkers: BRCA1 mutation

At the latest follow-up in January 2012, she had no recurrence of ovarian cancer and was well.

PubMed CentralRead more →

Recurrent Stage III Ovarian Cancer in a BRCA1 Carrier Treated With Multiple Therapies

Patient Info: Anonymized, female, 40s | Stage III

Biomarkers: BRCA1 mutation

By late 2011, hilar nodal disease was slowly progressing and bevacizumab was started for the recurrent ovarian cancer.

PubMed CentralRead more →

Recurrent Stage III Ovarian Cancer Complicated by Severe Kidney Injury

Patient Info: Anonymized, female, 70+ | Stage III

After further intra-abdominal cancer progression and severe kidney injury, she developed seizures, encephalopathy, and limb ischemia and died 1 week after hospitalization in May 2011.

PubMed CentralRead more →

Stage III Ovarian Cancer in a BRCA1 Carrier Treated With Long-Term Maintenance Therapy

Patient Info: Anonymized, 50s | Stage III

Biomarkers: BRCA1 mutation

After long-term maintenance therapy, she had no evidence of ovarian cancer at the latest follow-up.

PubMed CentralRead more →

Recurrent Stage III Ovarian Cancer in a BRCA2 Carrier Treated Over Many Years

Patient Info: Anonymized, 40s | Stage III

Biomarkers: BRCA2 mutation

She later developed a separate aggressive oral squamous cell carcinoma and died in 2011 from acute airway obstruction during progression of that cancer.

PubMed CentralRead more →